CURB-65
iatroX editorial team · Updated · Record checked · editorial policy
CURB-65 stratifies community-acquired pneumonia severity using five bedside criteria to guide place-of-care decisions. Each criterion scores 1 point: Confusion, Urea >7 mmol/L, Respiratory rate ≥30, Blood pressure (systolic <90 or diastolic ≤60), and age ≥65.
inputs
evidence
derivation
Derived by Lim et al. (2003) from a prospective study of 1,068 patients with CAP across the UK, New Zealand, and the Netherlands. The five variables were selected from multivariate analysis of predictors of 30-day mortality.
validation
30-day mortality by score: 0 = 0.7%, 1 = 2.1%, 2 = 9.2%, 3 = 14.5%, 4 = 40%, 5 = 57% in the original cohort. Validated externally in multiple international cohorts. The BTS/NICE CAP guidelines use CURB-65 as a core severity assessment tool.
guideline endorsements
NICE NG250 recommends CURB65 plus clinical judgement for adults assessed in hospital with community-acquired pneumonia; use CRB65 in primary care. Place-of-care decisions also consider comorbidity, clinical concerns and support at home.
references
- Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377-382.PMID: 12728155
- NICE Guideline NG191. Pneumonia (community-acquired): antimicrobial prescribing. National Institute for Health and Care Excellence; 2019 (updated 2023).link ↗
- Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(Suppl 3):iii1-iii55.PMID: 19783532
- Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the ATS and IDSA. Am J Respir Crit Care Med. 2019;200(7):e45-e67.PMID: 31573350
- Supporting guidance — nice.org.uk (checked 14 November 2026).link ↗
- Supporting guidance — diasys.in (checked 14 November 2026).link ↗